SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Safal Herbs Ltd (532034) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 532034 NSE: | Pharmaceuticals & Drugs | Small Cap

Safal Herbs Share Price

0.84 0.00 (0.00%)
As on 11-Mar'20 18:01

Safal Herbs Ltd (532034)

BSE: 532034 NSE:
Key Metrics
Market Cap
₹14 Cr.
P/E Ratio
0.00
Price to Book (P/B)
1.54
Price to Sales (P/S)
41.07
EV/EBITDA
13773.12
Return on Capital Employed (ROCE)
0.03%
Current Price
₹0.8
Return on Equity (ROE)
0.02%
Return on Assets (ROA)
0.02%
Operating Profit Margin
0%
Net Profit Margin
INF%
Gross Profit Margin
0%
Book Value per Share
₹0.9
Sales Growth (YoY)
-100%
Sales Growth (3 Years)
-100%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹1 / 1
Net Profit Growth (3 Years)
-48.78%
Dividend Yield
0.00%
Promoter Holding
9.62%
Pledged shares (%)
of Promoter's holding (%)
0.00%

DeciZen - make an informed investing decision on Safal Herbs

Based on:

M-Cap below 100cr DeciZen not available

Safal Herbs stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
ROCE % 0.3%0.4%0.1%0%0.2%0.2%0.2%-0.2%-0.4%0%-
Value Creation
Index
-1.0-1.0-1.0-1.0-1.0-1.0-1.0-1.0-1.0-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.60.61.51.31.41.41.80.30.100
Sales YoY Gr.-12.5%142.9%-18.3%15.2%-2.1%25.5%-80.8%-70.6%-100%-
Adj EPS 0000.1000-0-000
YoY Gr.-NANANA-40%-100%NANANANA-
BVPS (₹) 0.90.90.98.88.80.90.90.90.90.90.9
Adj Net
Profit
0000.1000-0-000
Cash Flow from Ops. -00.2-0.3-04-0-40-00-
Debt/CF from Ops. 018-58-558.7000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%-100%-100%
Adj EPS NA-100%NANA
BVPS-0.1%-37%-0.4%0%
Share Price -19.8% -9.5% -15.3% -39.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on
Equity %
0.20.30.20.50.30.40.1-0.2-0.400
Op. Profit
Mgn %
57.10.65.32.81.7-7.4-10-46.804.3
Net Profit
Mgn %
3.44.813.71.92.40.6-4.1-31.900
Debt to
Equity
00.41.81.8000000-
Working Cap
Days
5,9116,2534,4787,3754,3172,3131,8429,56832,3170626
Cash Conv.
Cycle
1,5271,508673872514142-1865390625

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0.3 -
BVPS (₹) 0.9 -
Reserves (₹ Cr.) -1 -
P/BV 1.54 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 1.26 / 1.38
All Time Low / High (₹) 0.00 / 72.85
Market Cap (₹ Cr.) 13.8
Equity (₹ Cr.) 10
Face Value (₹) 1
Industry PE 43.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Safal Herbs - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Sales0.560.631.531.241.441.411.770.340.100
Operating Expenses + 0.530.581.521.241.401.421.910.370.150.05
Manufacturing Costs00000.010.010000
Material Costs0.440.511.451.061.241.251.810.320.080
Employee Cost 0.060.050.050.090.060.050.030.030.030.03
Other Costs 0.030.020.020.090.100.110.060.030.040.02
Operating Profit 0.030.040.010.010.04-0.01-0.13-0.03-0.05-0.05
Operating Profit Margin (%) 5.0%7.1%0.6%0.7%2.8%-0.6%-7.4%-10.0%-46.8%-
Other Income + 000.01000.020.150.020.020.06
Exceptional Items 0000000000
Interest 0000000000
Depreciation 0000000000
Profit Before Tax 0.030.040.020.010.040.020.02-0.01-0.030
Tax 0.010.010.0100.0100.01000
Profit After Tax 0.020.030.010.010.030.010.01-0.01-0.030
PAT Margin (%) 3.4%4.8%1.0%0.5%1.9%0.8%0.8%-4.1%-31.9%-
Adjusted EPS (₹)0.00.00.00.00.00.00.00.00.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20

Equity and Liabilities

Shareholders Fund + 8.898.928.948.948.978.988.998.988.948.95
Share Capital 10101010101010101010
Reserves -1.11-1.08-1.06-1.06-1.03-1.02-1.01-1.02-1.06-1.05
Debt +03.8415.8115.81000000
Long Term Debt03.8415.8115.81000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables0.270.210.550.600.060.2800.170.040
Others Liabilities 0.030.030.040.040.020.020.010.010.010.01
Total Liabilities 9.191325.3425.409.059.299.019.1698.96

Fixed Assets

Net Fixed Assets +0000000000
Gross Block0000000000
Accumulated Depreciation0000000000
CWIP 0000000000
Investments 0000000000
Inventories0.010.040.030.04000000
Trade Receivables2.872.803.583.551.210.260.010.320.180.07
Cash Equivalents 0.150.360.090.060.080.070.030.030.020.03
Others Assets 6.179.8121.6421.757.768.968.978.808.808.86
Total Assets 9.191325.3425.409.059.299.019.1698.96

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Cash Flow From Operating Activity + -00.21-0.27-0.034.02-0.01-4.040-0.020.01
PBT 0.030.040.020.010.040.020.02-0.01-0.030
Adjustment 000000-00-00
Changes in Working Capital -0.030.18-0.29-0.033.99-0.02-4.050.020.020.01
Tax Paid 0-0.01-0.01-0-0.01-0-0.0100-0
Cash Flow From Investing Activity + 0000-404000
Capex 0000000000
Net Investments 0000-404000
Others 0000000000
Cash Flow From Financing Activity + 0000000000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow -00.21-0.27-0.030.02-0.01-0.040-0.020.01

Finance Ratio

PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Ratios
ROE (%)0.210.340.170.070.320.130.16-0.16-0.360.02
ROCE (%)0.310.410.120.040.240.180.23-0.16-0.360.03
Asset Turnover Ratio0.060.060.080.050.080.150.190.040.010
PAT to CFO Conversion(x)-07-27-3134-1-404N/AN/AN/A
Working Capital Days
Receivable Days1,6991,643.10758.601,044.60604189.8027.101789110
Inventory Days6.2013.307.9010.40000000
Payable Days211.90169.8095.80199.7097.7050.4029.10100.405150

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Safal Herbs Ltd FAQs

The current trading price of Safal Herbs on 11-Mar-2020 18:01 is ₹0.84.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Mar-2020 the market cap of Safal Herbs stood at ₹13.80 Cr

The latest P/E ratio of Safal Herbs as of 10-Mar-2020 is 0.00.

The latest P/B ratio of Safal Herbs as of 10-Mar-2020 is 1.54.

The 52-week high of Safal Herbs is ₹1.38 and the 52-week low is ₹1.26.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Safal Herbs is ₹0.34 ( Cr.) .

About Safal Herbs Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×